Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Qishenyiqi Dripping Pill in Patients With Coronary Microvascular Disease

NCT06699420 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06699420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Qishenyiqi Dripping Pill in Patients With Coronary Microvascular Disease
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Recruiting
Start date
November 8, 2023
Completion date
June 30, 2026
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular disease